PainReform Ltd. (PRFX:NASDAQ) closed at $0.740 on October 23, 2026, up 2.76% on the day. The stock trades 90.7% below its 52-week high of $7.95 and 7.1% above its 52-week low of $0.691. Over the past year, it lost 88.7%. PainReform Ltd. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, PRFX closed higher on 89 days (35%). Its best day was May 29, 2026 (+118.98%) and its worst was June 1, 2026 (-32.67%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 6 times.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Find more stocks like PRFX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.